Autologous cytokine-induced killer (CIK) cell immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous cytokine-induced killer (CIK) cell immunotherapy, covering 2025-03-13 to 2025-03-13. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of Chemotherapy and PD-1 Inhibitor Combination With Autologous CIK Cell Immunotherapy to Treat Lung Cancer [Phase 2]